Shang‐Feng Tsai

机构：National Chung Hsing University, Tunghai University, Taichung Veterans General Hospital, National Taipei University · ORCID：0000-0002-6119-0587

发表论文 136 篇 · 总被引 1424 次 · h-index 15

代表论文

• Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial (2023 · The Lancet · 被引 286)
• Safety and effectiveness of COVID-19 vaccines in patients with IgA nephropathy: a retrospective cohort study from the TriNetX global collaborative networks (2023 · EClinicalMedicine · 被引 10)
• Effectiveness and safety of apixaban and warfarin in patients with new- onset atrial fibrillation after advanced chronic kidney disease or end-stage kidney disease (2025 · Heart Rhythm · 被引 8)
• Effects of AST-120 on mortality in patients with chronic kidney disease modeled by artificial intelligence or traditional statistical analysis (2024 · Scientific Reports · 被引 8)
• Safety of midodrine in patients with heart failure with reduced ejection fraction: a retrospective cohort study (2024 · Frontiers in Pharmacology · 被引 5)
• Exploring knowledge, attitude, and intention towards advance care planning, advance directive, and the patient self-determination act among hemodialysis patients (2023 · BMC Palliative Care · 被引 5)